Isolation and transplantation of multipotential populations of epidermal growth factor-responsive, neural progenitor cells from the canine brain.
Glial cell transplantation into myelin-deficient rodent models has resulted in myelination of axons and restoration of conduction velocity. The shaking (sh) pup canine myelin mutant is a useful model in which to test the ability to repair human myelin diseases, but as in humans, the canine donor supply for allografting is limited. A solution may be provided by self-renewing epidermal growth factor (EGF)-responsive multipotential neural progenitor cell populations ("neurospheres"). Nonadherent spherical clusters, similar in appearance to murine neurospheres, have been obtained from the brain of perinatal wildtype (wt) canine brain and expanded in vitro in the presence of EGF for at least 6 months. Most of the cells in these clusters express a nestin-related protein. Within 1-2 weeks after removal of EGF, cells from the clusters generate neurons, astrocytes, and both oligodendroglial progenitors and oligodendrocytes. Transplantation of lacZ-expressing wt neurospheres into the myelin-deficient (md) rat showed that a proportion of the cells differentiated into oligodendrocytes and produced myelin. In addition, cells from the neurosphere populations survived at least 6 weeks after grafting into a 14-day postnatal sh pup recipient and at least 2 weeks after grafting into an adult sh pup recipient. Thus, neurospheres provide a new source of allogeneic donor cells for transplantation studies in this mutant.
Milward
E A
EA
Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison 53706, USA.
Lundberg
C G
CG
Ge
B
B
Lipsitz
D
D
Zhao
M
M
Duncan
I D
ID
D000818:Animals; D016380:Brain Tissue Transplantation / Q000502:physiology*; D018929:Cell Culture Techniques / Q000379:methods; D002455:Cell Division / Q000187:drug effects; D003711:Demyelinating Diseases / Q000473:pathology / Q000628:therapy / Q000662:veterinary*; D004283:Dog Diseases; D004285:Dogs; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D017930:Genes, Reporter; D006801:Humans; D009474:Neurons / Q000166:cytology* / Q000502:physiology / Q000637:transplantation*; D009836:Oligodendroglia / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D051381:Rats; D013234:Stem Cells / Q000166:cytology* / Q000473:pathology / Q000502:physiology; D013997:Time Factors; D014162:Transfection; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous; D001616:beta-Galactosidase / Q000096:biosynthesis
D004815:Epidermal Growth Factor; D001616:beta-Galactosidase